Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Brazil
/
Healthcare
/
Fleury
FLRY3
Fleury
Brazil's Aging Population And Digitalization Will Boost Premium Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 11 Analysts
Published
27 Jul 25
Updated
09 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
R$19.50
26.8% undervalued
intrinsic discount
09 Aug
R$14.28
Loading
1Y
-9.9%
7D
0.3%
Author's Valuation
R$19.5
26.8% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
R$19.5
26.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
7b
2014
2017
2020
2023
2025
2026
2028
Revenue R$0
Earnings R$0
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
6.20%
Healthcare Services revenue growth rate
0.29%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
17.83%
Calculation
R$0
Earnings '28
x
16.54x
PE Ratio '28
=
R$0
Market Cap '28
R$0
Market Cap '28
/
543.87m
No. shares '28
=
R$0
Share Price '28
R$0
Share Price '28
Discounted to 2025 @ 17.82% p.a.
=
R$0
Fair Value '25